Trials / Active Not Recruiting
Active Not RecruitingNCT06546332
Post Market Clinical Follow-Up KeriFuse®
Effectiveness and Safety of the KeriFuse® Intramedullary Arthrodesis Implant and Associated Instruments in the Treatment of IP or DIP Arthritis: a Post Market Clinical Follow-up.
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (estimated)
- Sponsor
- Keri Medical SA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The general objective of this study is to evaluate the performances and the safety related to the KeriFuse® intramedullary arthrodesis implant and associated instrumentation used in accordance with their approved labelling and instruction for use. Performance and safety of KeriFuse® intramedullary arthrodesis implant will be established on short and middle-terms in regards to the implant life-cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | KeriFuse® | The intramedullary arthrodesis Implant (KeriFuse®) is indicated for consolidation or bone fusion (arthrodesis) of degraded or arthritic distal interphalangeal (DIP) of hand digits or interphalangeal (IP) joint of the hand thumb. |
Timeline
- Start date
- 2022-07-05
- Primary completion
- 2025-12-01
- Completion
- 2027-03-01
- First posted
- 2024-08-09
- Last updated
- 2025-09-11
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT06546332. Inclusion in this directory is not an endorsement.